1,571 results on '"Mauri, Laura"'
Search Results
2. Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program
3. Identification of the Lipid Antigens Recognized by rHIgM22, a Remyelination-Promoting Antibody
4. Alkali-labile gangliosides
5. The Ganglioside Structures: Chemistry and Biochemistry
6. Gangliosides and Cell Surface Ganglioside Metabolic Enzymes in the Nervous System
7. GM1 oligosaccharide efficacy against α-synuclein aggregation and toxicity in vitro
8. Massive Accumulation of Sphingomyelin Affects the Lysosomal and Mitochondria Compartments and Promotes Apoptosis in Niemann-Pick Disease Type A
9. Gangliosides and Cell Surface Ganglioside Metabolic Enzymes in the Nervous System
10. NEMATOIDE ENTOMOPATOGÊNICO: UM RESUMO
11. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial
12. Novel insights on GM1 and Parkinson's disease: A critical review
13. Galactocerebrosidase deficiency induces an increase in lactosylceramide content: A new hallmark of Krabbe disease?
14. Glycosphingolipids
15. Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization: Insights From VOYAGER PAD
16. Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial
17. Biomarkers of platelet activation and cardiovascular risk in the DAPT trial
18. Turning the spotlight on the oligosaccharide chain of GM1 ganglioside
19. Causes of late mortality with dual antiplatelet therapy after coronary stents
20. Modulation of calcium signaling depends on the oligosaccharide of GM1 in Neuro2a mouse neuroblastoma cells
21. 5 Medtronic
22. Interruption of Dual Antiplatelet Therapy Within Six Months After Coronary Stents (from the Dual Antiplatelet Therapy Study)
23. Gangliosides in the differentiation process of primary neurons: the specific role of GM1-oligosaccharide
24. The oligosaccharide portion of ganglioside GM1 regulates mitochondrial function in neuroblastoma cells
25. Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis
26. Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention
27. Glycosphingolipids
28. 2019 AATS/ACC/ASE/SCAI/STS expert consensus systems of care document: A proposal to optimize care for patients with valvular heart disease: A joint report of the American Association for Thoracic Surgery, American College of Cardiology, American Society of Echocardiography, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
29. Risk of Sequelae of COVID-19 in Children Cared for by Primary Care Pediatricians
30. Olericulture No-Till System at Mountain Region: Physical and Biological Attributes of the Soil.
31. GM1 ganglioside exerts protective effects against glutamate‐excitotoxicity via its oligosaccharide in wild‐type and amyotrophic lateral sclerosis motor neurons
32. Isolation and Analysis of Lipid Rafts from Neural Cells and Tissues
33. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
34. Canibalism in the larval instars of Spodoptera frugiperda (J. E. Smith, 1797) (Lepidoptera: Noctuidae): temperature and food quantity
35. Comparability of Event Adjudication Versus Administrative Billing Claims for Outcome Ascertainment in the DAPT Study: Findings From the EXTEND-DAPT Study
36. Cell density-dependent membrane distribution of ganglioside GM3 in melanoma cells
37. Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial
38. Update on antithrombotic therapy after percutaneous coronary revascularisation
39. Usefulness of Intracoronary Brachytherapy for Patients With Resistant Drug-Eluting Stent Restenosis
40. Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study
41. Long-Term Outcomes of Stenting the Proximal Left Anterior Descending Artery in the PROTECT Trial
42. 5-Year Safety and Efficacy of Resolute Zotarolimus-Eluting Stent: The RESOLUTE Global Clinical Trial Program
43. Parkinson’s disease recovery by GM1 oligosaccharide treatment in the B4galnt1+/− mouse model
44. Use of Administrative Claims Data to Estimate Treatment Effects for 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study
45. Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention: A Subgroup Analysis From the REDUAL PCI Trial
46. Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients With ST-Segment Elevation Myocardial Infarction in the United States
47. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
48. Neuronal membrane dynamics as fine regulator of sphingolipid composition
49. Assignment by Negative-Ion Electrospray Tandem Mass Spectrometry of the Tetrasaccharide Backbones of Monosialylated Glycans Released from Bovine Brain Gangliosides
50. GM1 Oligosaccharide Efficacy in Parkinson’s Disease: Protection against MPTP
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.